We analyzed expression of MET, its ligand HGF and DEGs (GYS1, H6PD, HK2, MDH1B, PDK2, PDK4, PDPR, PFKL, PHKG1, PKLR and SLC2A1) in normal and tumor tissues of liver hepatocellular carcinoma (LIHC) cohort of The Cancer Genome Atlas (TCGA) via UALCAN28. The gene discussed is MET; the disease is neoplasm.